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Partial biochemical and physicochemical characterization of organic
macromolecules in urine from patients with renal stones and control
subjects. From the urine of patients with calcium nephrolithiasis, and of
control subjects, we isolated organic substances according to molecular
size and tested them for effects on calcium oxalate precipitation. Nine
subgroup materials of varying sizes were prepared by ultrafiltration and
Sephadex G-200 column chromatography from 10 stone-formers, as
well as from 10 control subjects. Uromucoid was found in large
materials of both groups, whereas glycosaminoglycans were detected in
large- and medium-sized materials of both groups. The small materials
were devoid of uromucoid and glycosaminoglycans, but contained
protein and uronic acid, a finding suggesting that they may be glycopro-
teins. The daily excretion of the uromucoid-rich material was greater,
but that of the small glycoproteins was lower in stone-formers than in
control subjects. The largest-sized material from stone-formers was
devoid of any activity on calcium oxalate precipitation. All of the
remaining materials (at a concentration of 5 mg/dl) exerted inhibition on
calcium oxalate precipitation. The inhibition rose progressively with the
decreasing size of organic materials. The calculated total inhibitor
activity for the stone-forming group was 36% lower than that obtained
in the control group.
Caractérisation partielle biochimique et physico-chimique de macro-
molecules organiques dans l'urine de malades atteints de lithiase rénale et
dans l'urine de sujets contróles. Des substances organiques Ont été
isolées de l'urine de malades atteints de lithiase rénale calcique et de
l'urine de sujets contrôles. L'isolement a été fonction de Ia taille
moléculaire. Ces substances ont été étudiées pour leur effet sur Ia
precipitation de l'oxalate de calcium. Neuf sous-groupes de différentes
tailles moléculairesont été prCparés par ultrafiltration et chromatogra-
phie sur colonne de Séphadex G-200 a partir de l'urine de 10 sujets
lithiasiques et de 10 sujets contrôles. L'uromucoIde a été mis en
evidence dans les sous-groupes de taille moléculaire élevée dans les
deux categories de sujets. alors que les glycosaminoglycans ont été
détectés dans les sous-groupes de grande et moyenne taille moléculaire
dans les deux groupes de sujets. Les sous-groupes de petite taille
moléculaire étaient dépourvus d'uromucoIde et de glycosaminoglycans
mais contenait des protéines et de l'acide uronique, constatation qui
suggère qu'il puisse d'agir de glycoprotéines. L'excrétion quotidienne
de materiel riche en uromucoIde était plus grande chez les lithiasiques
chez les sujets contrôles, mais celle des petites glycoproteines était
inférieure chez les sujets lithiasiques. Le materiel de grande taille
molCculaire provenant des sujets lithiasiques était dépourvu d'activité
sur Ia precipitation de l'oxalate de calcium. Tous les autres matériels (a
une concentration de 5 mg/dl) exercaient une inhibition sur Ia précipita-
tion de l'oxalate de calcium. L'inhibition augmentait progressivement
avec Ia diminution de Ia taille des substances organiques. L'activité
inhibitrice totale calculée pour le groupe lithiasique était de 36%
inférieure a celle observée dans Ic groupe contrôle.
379
Urine contains organic macromolecules, as well as mineral
electrolytes [1]. Many studies have examined the contribution
of urinary electrolytes on urinary saturation, nucleation, and
growth of "stone-forming" substances [2—4].But only a limited
number of reports [5—111 have been published with regard to the
crystallization effect of urinary macromolecules.
Urinary macromolecules are mainly composed of glycopro-
teins, glycopeptides, and heteropolysaccharides [1]. Although
Tamm-Horsfall (T-H) glycoprotein [121 and uromucoid [51 are
the major glycoproteins occurring in urine, other glycoproteins
[7, 13] and glycopeptides [14, 15] have been identified. Almost
all of the urinary heteropolysaccharides probably consist of
glycosaminoglycans (GAGS).
Several glycoproteins (or glycopeptides) and GAGS have
been found to be inhibitors of calcium oxalate (CaOX) cry stalli-
zation. Nakagawa, Kaiser, and Coe [10] isolated from normal
urine two acidic polypeptides that were inhibitors of CaOX
crystal growth. Gill et al [91 and Bowyer, Brockis, and McCul-
loch [11] showed that whole urinary macromolecules had
inhibitory effects on the crystallization of CaOX. In addition,
Bowyer et al Ill] from normal urine isolated GAGS that showed
very strong inhibitory activity toward CaOX crystallization. We
have shown previously that synthetic heparin and chondroitin
sulfate are inhibitors of the spontaneous precipitation of CaOX,
because they increased the formation product ratio of CaOX
[16].
There has been no report, however, in which a comparison
has been made of effects of urinary macromolecules on CaOX
crystallization, among various macromolecular fractions, and
for each fraction, between patients with stones (stone-formers)
and control subjects. Although systematic fractionation of
nondialyzable material of normal urine was done by King et al
[17], Bourrillon and Kaplan [181, and Berggard [19], some of the
fractions may have been damaged by their preparative proce-
dures. Furthermore, the fractions were not arranged in molecu-
lar weight order.
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In this report, we examined the activity of urinary organic
substances of varying sizes on spontaneous precipitation of
CaOX from calcium stone-formers and normal subjects. Urine
samples from stone-formers and normal controls were separat-
ed systematically on a molecular weight basis, and each compo-
nent was tested for the effect on CaOX precipitation.
Methods
Patients and controls. A 24-hour urine sample was collected
from each of 10 active calcium stone-formers who were not
undergoing treatment and from each of 10 normal control
subjects who had been matched for race, age, and sex. For the
10 stone-forming patients, 5 were men (all white from age 22 to
56 years; mean age, 35 13 years) and 5 were women (all white
from age 23 to 61 years; mean age, 41 16 years). Two patients
were classified as having absorptive hypercalciuria type I, 3 as
absorptive hypercalciuria type II, 3 as renal hypercalciuria, and
2 as no metabolic abnormality. This classification scheme has
been described previously elsewhere [20]. All the patients
formed stones of CaOX and/or calcium phosphate (CaP) during
the preceding year. None had an acute urinary tract infection
during the study. None of the control subjects had a history of
renal stones or infection, bone disease, or gastrointestinal
disease. All the patients and control subjects had endogenous
creatinine clearances of 80 mI/mm or greater.
Initial separation by ultrafiltration (Fig. 1). Each urine sam-
ple was kept at 40 C throughout the period of urine collection
without any preservatives and was treated separately on the
day when the 24-hour urine collection was completed. Only
clear urine samples were chosen for this experiment. Any
sample which had a visible precipitate was discarded. Individ-
ual urine volumes ranged from 1500 to 3000 mI/day. The mean
urine volumes did not differ significantly between the two
groups. Two-thirds (in volume) of each 24-hour urine sample
was filtered initially through a 0.8-p.m Millipore filter (Millipore
Corporation, Bedford, Massachusetts) and then through a 0.45-
p.m filter. The filtrate was ultrafiltered through a 50,000-dalton-
capacity hollow-fiber filter (Amicon Corporation, Lexington,
Massachusetts) until the volume was reduced to 100 ml. The
ultrafiltrate collected in this way was stored at 4° C for 1 to 2
hours until further processing, as described below, could be
performed. The 100 ml of retentate from the 50,000-dalton
hollow fiber filter was again reultrafiltered with 400 ml of
distilled water through the 50,000-dalton hollow-fiber filter until
the volume was reduced to 100 ml. This washing procedure with
400 ml of distilled water was performed three more times to
remove all the electrolytes and substances smaller than 50,000-
daltons from the retentate. The "washed" retentate was then
centrifuged at x 12,100 g for 10 mm at 4° C. The supernatant
was lyophilized, weighed, and kept at —20° C until further
studies were performed. This material was designated as the
"X" substance (0.45 p.m > "X" > 50,000 daltons).
The filtrate from the 50,000-dalton hollow-fiber filter was
ultrafiltered through a 5,000-dalton hollow-fiber filter (Amicon
Corporation) until the volume was reduced to 100 ml. The
retentate was ultrafiltered four times with 400 ml of distilled
water through the 5,000-dalton hollow-fiber filter as described
above for the "X" substance. The washed retentate was
centrifuged at x12,l00 g for 10 mm at 4° C. The supernatant
was lyophilized, weighed, and kept at —20° C. This material
centrifuge
12,100 X 9
supernatant
lyophilize
was designated as the "Y" substance (50,000-daltons> "Y" >
5,000 daltons). All procedures described above were performed
on ice or in a cold room (4° C).
After all 20 urine samples had been treated, "X" and "Y"
substances were divided into four groups as follows: stone X
material (10 "X" substances from stone-formers); stone Y
material (10 "Y" substances from stone-formers); control X
material (10 "X" substances from control subjects), and control
V material (10 "Y" substances from control subjects). The 10
lyophilized samples from each group were reconstituted with 36
ml of distilled water and lyophilized again to yield a single
pooled specimen for each of the four groups.
Further separation by column chromatography. One hundred
milligrams of the reconstituted and lyophilized material of each
group were dissolved in 7 ml of 0.025 M sodium chloride and
applied to a column (2.6 x 100 cm) of Sephadex G-200. Eight-
milliliter fractions were collected, and the protein content of
each fraction was determined by the method of Lowry et al [21],
All gel filtrations were performed at 4° C. The void volume (184
ml) was determined from the elution volume of Blue Dextran
2000, and the column was calibrated with gel filtration stan-
dards purchased from Pharmacia Fine Chemicals, Uppsala,
Sweden.
Based on the protein elution profile, several sequential frac-
tions obtained by column chromatography from each group
were combined into four to five pools (subgroups). From stone-
X and control-X materials, five subgroups each were obtained
(X-a, X-ab, X-b, X-bc, and X-c). Stone-Y and control-Y
materials were divided into four subgroups each (Y-a, Y-b, Y-
be and Y-c). Each subgroup material was then dialyzed (Spec-
trapor membrane; nominal cutoff, 12,000 to 14,000 daltons)
against 4 liters of distilled water for 24 hours at 4° C and
lyophilized. The lyophilized materials were weighed and stored
at —20° C until further study.
2/3 of 24-hour urinet
0.8 pm filtrationt
0.45 pm filtration
+
hollow-fiber ultrafiltration
exclusion-limit, 50,000 daltons
Retentate Filtrate
washed 4 times with hollow-fiber ultrafiltration
distilled water exclusion limit, 5,000 daltons/
Retentate Filtrate
washed 4 times with (discard)
distilled water
I centrifuge
12,100 X g
su pernatant
lyophilize
"X" substance
(0.45 1km > 'X" > 50,000 daltons)
"Y" substance
(50,000 daltons > 'Y" > 5,000 daltons)
Fig. 1. Initial separation of urinary organic substances by ultrafiltration.
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Determinations of uromucoid, protein, uronic acid and gly-
cosaminoglycans. Qualitative assay of uromucoid was per-
formed on an Ouchterlony 1.5% agarose gel plate (Melow Co.,
Springfield, Virginia) [221. Briefly, 20 p.l of human uromucoid
antiserum (1:1 dilution with distilled water, Boehringer Mann-
heim Co., Indianapolis, Indiana) was applied to the center well.
Lyophilized material from each subgroup was suspended in
distilled water at a concentration of 5 mg/mI with 0.3% sodium
dodecyl sulfate. Twenty microliters of this preparation was
applied to one of the surrounding five wells. The plate remained
at room temperature for 24 to 48 hours to develop a visible
antigen-antibody reaction.
For the measurement of protein, uronic acid and GAGS (500
g/ml of solution of lyophilized material from each subgroup)
was used. Bovine serum albumin (Sigma Chemical Co., St.
Louis, Missouri) was used as the standard for protein determi-
nation, and the results were expressed as equivalent concentra-
tions of bovine serum albumin.
Uronic acid was measured by the modified uronic acid
carbazole reaction [23]. GAGS were measured by the modified
method of Whiteman [24], in which a sodium chloride concen-
tration of 0.58 M is used to precipitate all the uromucoids.
Chondroitin-4-sulfate (chondroitin sulfate sodium salt, Type A,
from whale cartilage purchased from Sigma Chemical Co.) was
used as the standard in the measurements of uronic acid and
GAGS, and the results were expressed as equivalent concentra-
tions of chondroitin-4-sulfate.
Calcium oxalate precipitation. The effect of each subgroup
material on the spontaneous precipitation of CaOX was exam-
ined in vitro, according to the method described previously
[16]. The formation product of CaOX was determined in
synthetic medium containing I m calcium chloride, 2 mrvi
magnesium chloride, and 136 m sodium chloride buffered to
pH 6.5 with 5 msi sodium cacodylate and at 37° C. The control
solution was devoid of subgroup material. Test solutions com-
prised the synthetic media to which one of the subgroup
materials had been added at a concentration of 50 p.g!ml. To
each solution, increasing amounts of oxalate (as a solution of
sodium oxalate, 1 mg/ml) were added. Precipitation of CaOX at
3 hours was detected visually and confirmed from the solution
depletion of calcium and oxalate. The minimum oxalate concen-
tration that resulted in CaOX precipitation was determined by
interpolation, and from the value, the activity product of CaOX
was calculated [25]. This activity product represented the
formation product, or the minimum supersaturated state that
allowed precipitation of CaOX. Because solutions invariably
contain particle impurities, the formation product probably
provided a measure of heterogeneous nucleation.
Because of the limited amount available, only one concentra-
tion of subgroup material (5 mg/dl) was tested. Selected experi-
ments indicated that this concentration did not produce maxi-
mum effects on the formation product, because addition of
more subgroup material caused further change in the formation
product.
The effect of subgroup material on CaOX nucleation was
assessed from the fractional change in formation product as:
formation producte — formation product0
where formation producte represents the value obtained in the
presence of subgroup material, and formation product0 is
control value without subgroup material.
Thus, a positive value for fractional change in formation
product indicated inhibition of CaOX precipitation; and a
negative value, a promotion. The formation product was mea-
sured in duplicate or triplicate. Replicate values agreed to
within 4% of the mean.
Calcium was measured by atomic absorption spectropho-
tometry; oxalate, by the method of Hodgkinson and Williams
[26]; sodium and potassium, by flame photometry; and phos-
phorus, by the method of Fiske and Subbarow [27].
Statistical methods. Results were presented as the mean
Comparisons between groups were made by Student's
test and by Wilcoxon sum of ranks test.
Results
Initial separation by ultrafiltration. As shown in Table 1, the
average yield of the "X" substance of stone-formers was not
significantly different from that of control subjects, whereas the
yield of the "Y" substance of stone-formers was significantly
less than that for the "Y" substance of control subjects (56.3
14.1 vs. 97.4 53.3 mg/person/day, P < 0.05 by Student's t test
and P < 0.01 by Wilcoxon sum of ranks test).
Further separation by column chromatography. Protein elu-
tion patterns of the four group materials (stone X, stone Y,
control X and control Y) are demonstrated in Figures 2 and 3.
There were three major peaks in stone X but only two in control
X (Fig. 2). On the other hand, only one high peak was seen in
stone Y, and two major peaks were seen in control Y (Fig. 3).
On the basis of elution profiles, several sequential fractions
were combined to yield subgroup materials (X-a to X-c and Y-a
to Y-c).
Yields of the various subgroup materials on Sephadex G-200
column chromatography are shown in Table 2. Total recovery
or yield (sum of subgroup materials in each group) from 100 mg
applied to the column ranged from 45.2 mg (for control Y) to
60.3 mg (for stone Y). The amount of each subgroup material
was expressed as the percentage of the total yield in each group
(Table 2). As compared with control X, stone X contained a
higher percentage of X-a (26.3% vs. 17.2%) and a lower amount
of X-b (19.8% vs. 26.3%). As compared with control Y, stone Y
had much lower amounts of Y-c (13.8% vs. 23.0%).
From the percentage of each subgroup material within each
group, and assuming full recovery from the chromatography
procedure, we calculated, correcting daily, the excretion for
each subgroup (Table 2). The amount of X-a material in stone-
formers was still greater than that in control subjects. The
amount of Y-c in stone-formers was less than it was in control
subjects by a wider margin (7.7 vs. 22.4 mg/person/day),
because of lower amounts of stone Y than control Y.
Immunologic and chemical analyses of each subgroup mate-
rial. A clear antigen-antibody reaction with uromucoid antibody
was obtained in the materials from subgroups X-a, X-ab, and
X-b of stone-formers, whereas the reaction could be seen only
in X-a and X-ab subgroups of control subjects. The reaction
was most intense for X-a subgroup in both stone-formers and
control subjects.
Although the composition of protein, uronic acid, and GAGS
for the nine subgroup materials were similar between stone-
formers and control subjects (Fig. 4), some differences were
formation product0
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Table 1. Yields of "X" and "Y" substance in stone-formers and
control subjectsa
Average yield
mg/person/day
Stone-formers
(N= 10)
Control subjects
(N= 10)
X
Y
61.6 19.5
56.3 14.1*
71.6 18.0
97.4 53.3
a Yield for each subject was corrected and expressed on a per day
basis, by multiplying the value for 2/3 of 24-hour urine with 3/2. Mean
SD values for stone-formers and control subjects are shown. Significant
difference between stone-formers and control subjects is shown by
asterisk (*) for P < 0.05 (Student's t test) and P < 0.01 (Wilcoxon sum
of rank test). "X" substance probably contained substances <0.45 sm
but >50,000 daltons, whereas "Y" comprised substances <50,000 but
>5,000 daltons.
evident. First, the protein concentration of subgroups X-a to
X-b for stone-formers was moderately higher than it was in
control subjects. Second, the uronic acid concentration of
subgroup Y-c for stone-formers was less than it was in the same
subgroup material for control subjects. Third, the ratio of
uronic acid to protein was lower for Y-c subgroup in stone-
formers (0.43) than it was in control subjects (0.66).
No calcium could be detected in subgroup materials X-a to
Y-bc for stone-formers and control subjects, but Y-c subgroup
material of stone-formers and control subjects contained about
0.7% calcium on a weight basis.
Effect of subgroup materials on calcium oxalate precipita-
tion. When a fixed amount of each subgroup material (5 mg/dl)
was tested, the fractional change in formation product of CaOX
rose progressively with decreasing size of subgroup materials
from X-a to Y-c (Table 3) in both stone-formers and control
subjects. The results suggested that greater inhibitor activity
against CaOX precipitation resided in the smaller-sized sub-
2 X io daltons 1,375 daltons
Y—a Yb Yc
46—55 56-63 66—71I. I H —I
Y — bc
64,65
2 X 106 daltons 2 X i0 daltons
X—a X—ab X—b X—c
25—29 30—38 39—43, 47—51
p • I I—.————••I l—.——1 I—.——..I
X — bc
44 46
300
200
100
I
I
Fig. 3. Protein elution patterns of stone- Y and control- Y material by
Sephadex G-200 column chromatography. A 100-mg sample from either
stone-formers or control subjects was applied to the column. Y-a to Y-c
are subgroups separated according to the elution profile of protein
concentration.
200
100
400
I
I
35 45 55 65 75
Fraction no.
200
100
25 35 45 55
Fraction no.
Fig. 2. Protein elution patterns of stone-X and control-X material by
Sephadex G-200 column chromatography. A 100-mg sample from either
stone-formers or control subjects was applied to the column. X-a to X-c
are subgroups separated according to the elution profile of protein
concentration.
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Table 2. Yields of nine subgroups in stone-formers and control subjects on Sephadex 0-200 column chromatographya
Stone-formers Control subjects
Corrected daily Corrected daily
Subgroup Fraction Yield Total yield excretion Yield Total yield excretion
no. mg % mg/person/day mg % mg/person/day
X-a (25—29) 15.8
Stone X
26.3 16.2 8.8
Control X
17.2 12.3
X-ab (30—38) 18.1 30.1 18.6 15.3 30.0 21.5
X-b (39—43) 11.9 19.8 12.2 13.4 26.3 18.8
X-bc (44—46) 5.1 8.5 5.2 6.3 12.4 8.9
X-c (47—51) 9.2 15.3 9.4 7.2 14.1 10.1
Total 60.1 100.0 61.6 51.0 100.0 71.6
Y-a (46—55) 14.4
Stone Y
23.9 13.5 10.2
Control Y
22.6 22.0
Y-b (56—63) 32.3 53.5 30.1 21.5 47.6 46.4
Y-bc (64—65) 5.3 8.8 5.0 3.1 6.8 6.6
Y-c (66—71) 8.3 13.8 7.7 10.4 23.0 22.4
Total 60.3 100.0 56.3 45.2 100.0 97.4
a A 100-mg sample of each group material was applied to the column. This column chomatography was performed twice in each group, and the
average is shown in this table. Replicate values agreed to within 5% of each other. The corrected daily excretion was derived by multiplying the
percentage of each subgroup material with the amount of corresponding group material (Table I), and divided by 100.
Stone-formers
100 100
X-a X-ab X-b X-bc X-c V-a V-b Y-bc V-c
Subgroup
Control subjects
•—. Protein
0—0 Uronic acid
Glycosaminoglycans
•
/0
I I
X-a X-ab X-b X-bc X-c V-a V-b V-bc V-c
Subgroup
groups. The X-a material from stone-formers had no effect on
CaOX precipitation (fractional change in formation product of
zero), but that from control subjects had a modest inhibitor
activity (+0.29 fractional change). Y group materials from
stone-formers had, however, a slightly higher inhibitor activity
(more positive fractional change in formation product) than did
those from control subjects, None of the subgroup materials
exerted a promoter activity (negative fractional change).
Because the daily excretion of subgroup materials differed,
an estimate of the total inhibitor activity of each subgroup
material for each person per day was derived. Dividing correct-
ed daily excretion rate of each subgroup material (Table 2) by
five gave the relative excess of daily output over the fixed
amount (5 nig/dI) tested in formation product studies, assuming
same volume of solution (100 ml). The product of this value and
the fractional change in the formation product yielded an
400
300
200I
400
300
200I
0
/
0
Fig. 4. Protein, uronic acid, and glycosaminoglycans concentrations of nine subgroups in stonefor,ners and control subjects. All lyophilized
samples were suspended in distilled water at a concentration of 500 .cg/ml prior to assay.
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Table 3. Calcium oxalate precipitation study of nine subgroups of stone-formers and control subjects with synthetic solution"
Subgroup
Stone-formers Control subjects
Fractional change
in formation product
Total inhibitor
activity/person/day
Fractional change
in formation product
Total inhibitor
activity/person/day
X-a
X-ab
X-b
X-bc
X-c
0
+0.29
+0.34
+0.69
+0.87
0
+ 1.08
+ 0.83
+ 0.72
+ 1.64
+0.29
+0.59
+0.69
+0.69
+0.69
+ 0.71
+ 2.54
+ 2.59
+ 1.23
+ 1.39
Y-a
Y-b
Y-bc
Y-c
Total
+0.78
+1.08
+1.27
+1.17
+ 2.11
+ 6.50
+ 1.27
+ 1.80
+15.95
+0.69
+0.87
+0.87
+0.98
+ 3.04
+ 8.07
+ 1.15
+ 4.39
+25.11
A concentration of each subgroup material of 5 mg/dl was used for derivation in fractional change in formation product of calcium oxalate.
Total inhibitor activity reflects estimated activity residing in total amount of each subgroup excreted daily per person.
estimate of total inhibitor activity (per person per day, if all
inhibitor materials excreted each day are considered to be
contained in 100 ml). This calculation assumed that the inhibitor
activity was linear over the range of subgroup concentration of
subgroup material. This assumption was made primarily for the
purpose of comparison of inhibitor activity between subgroup
materials. It was practically impossible to determine whether
the inhibitor activity was additive over the total concentration
range of subgroup material. The total inhibitor activity in the
stone-forming group was 36% lower than the value obtained in
the control group (P < 0.02, by Wilcoxon sum of ranks test for
unpaired data). This significant difference, however, would be
relevant only if one assumes additivity of activity and equiva-
lent recovery of subgroup materials during preparative proce-
dure.
Discussion
This report represents a preliminary study of the biochemical
and physicochemical characterization of urinary organic sub-
stances from stone-formers and control subjects. These sub-
stances were isolated from fresh urine and separated according
to size into nine subgroups by ultrafiltration and Sephadex G-
200 column chromatography. Each subgroup material was
examined for content of uromucoid, protein, uronic acid, and
glycosaminoglycans (GAGS), and tested for effect on spontane-
ous nucleation of calcium oxalate (CaOX). Although use of the
Diaflo hollow-fiber membranes for preparation of the X and Y
groups should not, according to the manufacturer's specifica-
tions, have markedly altered the composition of the X and Y
substances, we cannot rule out the possibility that alteration in
these fractions could have occurred from shear-forces and
nonspecific absorption to the membrane. Unfortunately, ex-
periments to assess whether such changes in the structure of
these substances were occurring were not performed.
The large molecular weight subgroups (X-a, X-ab, and X-b
from stone-formers and X-a and X-ab from control subjects)
probably contained uromucoid, because of positive immunolog-
ic reactivity to uromucoid antibody. Although the exact size of
these subgroup materials was not determined, their estimated
size from elution patterns on Sephadex G-200 column chroma-
tography was compatible with reported molecular weight for
uromucoid [28]. Because these X subgroup materials also
contained GAGS, they are probably heterogeneous in composi-
tion, composed of uromucoid and GAGS as two major compo-
nents. In medium-sized subgroup materials (X-bc, X-c, and Y-a
from stone-formers and X-b, X-bc, X-c, and Y-a from control
subjects), GAGS probably represented the major constituent,
since GAGS but not uromucoid were identified. The estimated
size from elution patterns on column chromatography of greater
than 20,000 daltons was within the range described for GAGS
[29]. The third type of organic materials was found in low
molecular weight subgroups (Y-b, Y-bc, and Y-c). Uromucoid
could not be detected, and GAGS were low or absent. These
subgroup materials were composed of uronic acid and protein,
and may contain other unknown or unmeasured substances.
The proportion of uronic acid increased with decreasing molec-
ular weight. Thus, the ratio of uronic acid to protein was higher
for Y-c than it was for Y-b. These uronic acid-rich materials
may represent some yet undiscovered glycoproteins or degra-
dation products of larger glycoproteins and/or GAGS.
It is apparent that GAGS may occur in different molecular
sizes. This finding could explain the presence of GAGS in
several subgroup materials. On the other hand, uromucoid may
represent large aggregates of monomeric glycoproteins t28]. It
is possible that the immunoreactive uromucoid identified in
subgroups X-ab and X-b may represent smaller aggregates than
that identified in X-a.
Some noteworthy differences in biochemical composition of
subgroup materials were apparent between stone-formers and
control subjects. Uromucoid was identified in three subgroups
(X-a, X-ab, and X-b) from stone-formers instead of two (X-a
and X-ab) from control subjects. The protein content of these
subgroup materials from stone-formers was higher than that of
corresponding subgroups from control subjects. The corrected
daily excretion of X-a material by an average stone-former was
greater than that for an average control subject. These findings
suggested that more uromucoid might be excreted by the stone-
forming group, and that the high molecular weight materials
from stone-formers might be richer in uromucoid, The medium-
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sized subgroup materials (X-b to Y-a) contained equivalent
proportion of GAGS and did not differ markedly in daily
excretion rates between stone-formers and control subjects.
But, the low molecular weight subgroup materials (Y-b to Y-c)
from stone-formers were lower in uronic acid/protein ratio than
in control subjects. Moreover, the daily excretion rate of these
"glycoproteins" were undoubtedly lower in the stone-forming
group.
An initial exploration of "structure-function relationship"
was provided from the assessment of the effect of urinary
organic substances on spontaneous precipitation of CaOX.
None of the subgroup materials had a promoter activity, since
they did not facilitate the precipitation of CaOX. The X-a
subgroup from stone-formers was devoid of any activity. The
remaining materials inhibited the precipitation of CaOX. This
inhibitor activity rose progressively with decreasing size of the
subgroup material. The results suggested that uromucoid-rich
subgroups had a small or no inhibitor activity, that GAGS-
containing fractions had a moderate activity, and that smaller
glycoproteins exerted greatest inhibition against CaOX precipi-
tation. This conclusion is compatible with published reports
showing promoter activity for uromucoid [6J and inhibitor
activity for GAGS and glycoproteins [9—11, 161.
The physicochemical effects of the subgroup materials were
qualitatively similar between stone-formers and control sub-
jects, except in the action of X-a. The X-a material from stone-
formers did not either inhibit or promote precipitation of CaOX,
whereas that from control subjects produced a mild inhibition.
The result could be explained by the presumed heterogeneous
composition of X-a material, containing uromucoid and GAGS
with possible opposing effects on CaOX precipitation. The
greater proportion of uromucoid in X-a from stone-formers
could account for the absence of inhibitory activity. Verifica-
tion would require isolation of uromucoid and demonstration
that it promotes CaOX precipitation. The total inhibitor activity
calculated for an average daily excretion was substantially
lower in the stone-forming group than in the control, owing
partly to the reduced inhibitor activity of uromucoid containing
materials and reduced excretion of smaller glycoproteins. It
must be reemphasized that our estimate of 36% greater total
inhibitory activity in the control group is based upon the
assumption that all of the inhibitory activity of the original urine
samples is represented by the individual subgroups. Because
we did not measure total inhibitory activity of the original urine
samples, our observed differences may be in error, particularly
if 10% or less of the total original inhibitory activity remained in
the isolated subgroups. But, if 50% or more of the total
inhibition is represented by the subfractions, then these differ-
ences may be significant.
It is thus apparent that stone-formers excreted a greater
amount of materials rich in uromucoid, possessing potential
promoter or low inhibitor activity and a reduced amount of
glycoproteins of high inhibitor activity. The relevance of this
finding in stone formation remains to be clarified.
Reprint requests to Dr. C. Y. C. Pak, Section of Mineral Metabolism,
Dept. of Internal Medicine, The University of Texas Health Science
Center, Southwestern Medical School, 5323 Harry Hines Blvd., Dallas,
Texas 75235, USA
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